Executive Profile

Samuel E. Lynch D.M.D., D.M.Sc. Founder, Chief Executive Officer, President and Director, BioMimetic Therapeutics Inc.

Age	Total Calculated Compensation	This person is connected to 4 Board Members in 4 different organizations across 2 different industries. See Board Relationships
53	$1,319,056 As of Fiscal Year 2011

Background

Dr. Samuel E. Lynch, D.M.D., D.M.Sc., founded BioMimetic Therapeutics Inc. (Former Name, Biomimetic Pharmaceuticals Inc.) in 1999 and has been its Chief Executive Officer and President since April 14, 1999. Dr. Lynch has financial knowledge and business acumen. Dr. Lynch built a highly profitable business while serving as Vice President of a subsidiary of Sankyo Pharmaceuticals. Dr. Lynch served as an Executive Director of Research and Development of a private research ... institute affiliated with Harvard University. Dr. Lynch served for four years at Luitpold Pharmaceuticals Inc., a US subsidiary of Daiichi Sankyo, Co., Ltd. as Vice President with responsibility of Osteohealth Co., a division focused on bone and tissue regeneration. Dr. Lynch has spent his career in health care management, product development, and earlier in academic medicine/dentistry, including research and patient care. Dr. Lynch served as the Chairman of BioMimetic Therapeutics Inc. from April 14, 1999 to August 2005. Dr. Lynch has been a Director of BioMimetic Therapeutics, Inc. since April 14, 1999. He has been a director of Capital Bank Financial Corp. since october 2012. He has been a Director of Green Bankshares Inc., since January 2008 and serves as a Director of GreenBank. He serves as a Director of The Tennessee Biotechnology Association. He served on the Faculty at Harvard for six years. He has published and lectured extensively worldwide. He is a Co-inventor of BioMimetic's technologies. Dr. Lynch received his D.M.D degree from Southern Illinois University Dental School in 1985 and a Certificate of Specialty as well as a Doctorate of Medical Sciences from Harvard Medical School in 1989.

Corporate Headquarters 389 Nichol Mill Lane Franklin, Tennessee 37067 United States Phone: 615-844-1280 Fax: 615-844-1281 Board Members Memberships Director The Tennessee Biotechnology Association 1999-Present Founder, Chief Executive Officer, President and Director BioMimetic Therapeutics Inc. 2008-N/A Director, Member of Audit Committee and Director of Greenbank Green Bankshares, Inc. 2012-Present Independent Director Capital Bank Financial Corp. Education Doctorate Harvard Medical School Doctorate 1985 SIU School of Dental Medicine Other Affiliations Green Bankshares, Inc. Harvard Medical School The Tennessee Biotechnology Association SIU School of Dental Medicine Capital Bank Financial Corp.

Annual Compensation Salary $477,909 Bonus $131,675 Total Annual Compensation $609,584 Stocks Options All Other Compensation $32,872 Exercisable Options $223,500 Unexercisable Options $398,203 Total Number of Options $621,703 Total Compensation Total Annual Cash Compensation $642,456 Total Short Term Compensation $609,584 Other Long Term Compensation $32,872 Total Calculated Compensation $1,319,056

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.